Trial · NCT02419417
Adverse events2,398
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,398
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 0.75 mg | 0 | 5 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 1.25 mg | 0 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 2 mg | 4 | 13 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 3 mg | 1 | 10 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 4.5 mg | 9 | 13 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule B - BMS-986158 2 mg | 1 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule B - BMS-986158 3 mg | 2 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule C - BMS-986158 2 mg | 1 | 6 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule C - BMS-986158 3 mg | 4 | 13 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1 Schedule C - BMS-986158 4.5 mg | 3 | 10 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2 Schedule A | 0 | 1 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 0.75 mg | 0 | 5 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 1.25 mg | 0 | 4 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 2 mg | 0 | 13 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 3 mg | 0 | 10 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule A - BMS-986158 4.5 mg | 0 | 13 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule B - BMS-986158 2 mg | 0 | 4 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule B - BMS-986158 3 mg | 0 | 4 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule C - BMS-986158 2 mg | 0 | 6 | |
| other | Leukopenia | Blood and lymphatic system disorders | Part 1 Schedule C - BMS-986158 3 mg | 0 | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02419417/events